Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06724185

Effects of LP28 on Immunity Enhancement in the Elderly

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Synbio Tech Inc. · Industry
Sex
All
Age
50 Years – 75 Years
Healthy volunteers
Accepted

Summary

Due to the increasing attention on aging-related health issues, this study focuses on the elderly population as participants. The aim is to investigate whether supplementation with Lactobacillus plantarum LP28 can effectively enhance immunity, reduce the frequency and severity of common cold infections, and ultimately promote overall health in the elderly.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLP28 capsuleLP28 capsule : 5.0×10\^9 CFU/capsule
DIETARY_SUPPLEMENTPlacebo CapsuleMaltodextrin

Timeline

Start date
2024-07-09
Primary completion
2025-06-30
Completion
2025-06-30
First posted
2024-12-09
Last updated
2024-12-09

Locations

2 sites across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06724185. Inclusion in this directory is not an endorsement.